Healixa Inc.

OTCPK:EMOR Stock Report

Market Cap: US$29.9m

Healixa Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Bret Hedges

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure4.1yrs

Recent management updates

Recent updates


CEO

Bret Hedges

less than a year
Tenure

Bret Hedges was SVP of Strategic Partnerships of Healixa Inc. until July 2026 and serves as its Chief Executive Officer from July 2026.


Leadership Team

NamePositionTenureCompensationOwnership
Bret Hedges
Chief Executive Officerless than a yearno datano data
Jason Bovell
Chief Financial Officerless than a yearno datano data
Ian Parker
Chief Technology Officerless than a yearno data0.10%
$ 30.7k
Diane Koontz
President of Healixa Health Careno datano datano data
0.08yrs
Average Tenure

Experienced Management: EMOR's management team is not considered experienced ( 0.1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Satyajit Deb
Member of Advisory Board4.6yrsno datano data
Michael Brubaker
Senior Advisor Sustainable Agriculture2.6yrsno datano data
Christopher Miller
Member of Advisory Board3.7yrsno datano data
Fig Annunziato
Independent Director4.6yrsno datano data
Dong Yun Kim
Independent Director4.6yrsno datano data
Christopher Galliano
Independent Director4.6yrsno datano data
Denver Riggleman
Director4.6yrsno datano data
Matthew A. Vogel
Directorno datano datano data
Ken Surritte
Senior Advisor Water Independence2.6yrsno datano data
Mitchell C. Shapiro
Senior Legal Advisor2.6yrsno datano data
Michael Ussery
Senior Advisor Foreign Relations2.6yrsno datano data
4.1yrs
Average Tenure

Experienced Board: EMOR's board of directors are considered experienced (4.1 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/15 10:13
End of Day Share Price 2026/08/11 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Healixa Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.